CClinicalTrials.gg
CompletedNCT03225430Updated Jul 15, 2022

Evaluation of a Cognitive Psychophysiological Treatment for Tourette Syndrome and Tic Disorders

An interventional study of Cognitive behavioural treatment for tics and Cognitive psychophysiological in Tic Disorder, Chronic Motor or Vocal, Tourette Syndrome in Children and Tourette Syndrome, sponsored by Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal. Completed at 1 site in Canada. Open to participants aged 8 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-07-15.

Sponsored by Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
8 Years to 65 Years
Sex
All
01

Study summary

It is a randomized controlled trial to compare two behavioural treatments, namely CBIT and CoPs. This study would be the first head-to-head randomized trial between two established treatments rather than supportive counseling or wait-list control. Thirty-six adults and 36 children with TS/TD will be recruited into each of the two (CBIT, CoPs) modalities requiring a total recruitment of 72 adults and 72 children over 5 years, which permits, even for a small-medium effect size, a robust power calculation. Motor performance measures will give concurrent validity to changes pre-post in TS/TD motor processes. Recruitment of both males and females will permit sex comparisons. The participants meeting inclusion/exclusion criteria will be assessed at pre-post 1 month and 6 months following treatment on standardized tic scales and global assessment of functioning. Participants will be treated individually on a weekly basis by therapists with an allegiance to each modality and outcome assessed by masked evaluation. The treatments are manualized and will last 10 weeks with 4 weeks of home practice at post-treatment with 6-month follow-up assessment on all outcome measures, plus motor performance measures post-treatment. All treatment sessions will be audio-recorded and assessed with implementation of treatment integrity procedures scales. The hypotheses are that: (1) the CoPs group will show superiority in clinically significant improvement on standard tic scale score, global functioning and quality of life than the CBIT group; and (2) changes in recognized parameters on selected motor tests scored according to published norms will change towards normalization post CoPs but not post CBIT. The outcome data from the two treatments will be analyzed by a mixed linear model adaptation of repeated measures MANOVA and daily diary measures will allow for an additive time series design over the 10 weeks treatment session. This design will allow computation of the size of treatment effects at different stages of therapy. The study results will impact on the treatment of choice and access to treatment for tic disorders and on the conceptualization of tic disorders.

Read the detailed description

Tics are defined as repetitive non-voluntary contractions of functionally related groups of skeletal muscles in one or more parts of the body. Gilles de la Tourette's syndrome (TS) forms a separate diagnostic category with multiple tics including vocal (phonic) tics occurring several times per day, for at least 1 year with onset before age 18. Persistent (chronic) tic disorder (TD) may involve a single motor or vocal tic. Tics peak around age 11 but can persist into adulthood with a prevalence of 1% and if untreated cause significant impairment. The current treatment guidelines for managing the tics recommend a Behavioural treatment, "habit reversal", which focuses on reversing the tic habit, now developed as a Comprehensive Behavioural Intervention for Tics (CBIT). CBIT involves multiple stages including awareness, relaxation, contingency training, positive reinforcement for not do the tic and the practice of a competing response antagonistic to the tic. A recent large scale multisite study compared CBIT with supportive therapy and found a significantly greater decrease in adults and children tics treated with CBIT. However, in both adult and child studies, 48-62% of samples were classified as non-responders. Effect sizes were medium (Cohen's d´= 0.55 - 0.68) compared to supportive therapy with mean tic decrease of 25-30% and samples remained symptomatic at follow-up. Research over the last 10 years (funded by the CIHR) have led to elaboration of a cognitive behavioural psychophysiological model of treatment (CoPs) of tic disorders. The CoPs is multi-modal and targets cognitive, behavioural and physiological processes characteristic of tic disorders rather than focusing on reversing the actual tic at onset. In the last funding period 2009-2013 the investigators have successfully applied the program to all subtypes and severity of adults with TS/TD both with and without comorbidity and compared outcome with a natural waitlist control. Results showed a clinically significant reduction of tic frequency following CoPs (Cohen's d- 1.43-2.34), maintained at 6-month follow-up. Validity of the CoPs model was supported by a change in behavioural and psychosocial as well as tic symptom measures post-treatment and at 6-month follow-up, and a post-treatment normalization of participants' performance on neuropsychological and electrophysiological measures.

02

Conditions studied

  • Tic Disorder, Chronic Motor or Vocal
  • Tourette Syndrome in Children
  • Tourette Syndrome
03

Who can participate

Ages eligible
8 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • presenting a simple/complex tic for at least one year occurring daily. Those included in the TS group, age 8-12 or 18-65, had a diagnosis of TS as the principal presenting problem accompanied by vocal tics. Those included in the TD group presented a simple/complex tic (vocal or motor) for at least one year occurring daily.

Exclusion criteria

Exclusion Criteria:

  • any major medical history, head injury including sensori-motor impairment, history of autism, Intelligence Quotient (IQ)\<75; other psychiatric problem on Axis I or II requiring treatment (minor comorbidities were accepted), any neurological problems (e.g., Parkinson's, hemifacial spasms, Meige syndrome, sclerosis; Huntington's disease, Wilson's disease); currently receiving treatment from a psychologist, acupuncture, hypnotherapist, massotherapist; currently receiving psychotropic drugs non-relevant to TS or ADHD or abuse of alcohol or drugs.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
144 participants (estimated)

Study arms

  • Active comparator
    Comprehensive Behavioural Intervention

    Participant will received psychoeducation about tic disorders, creating a tic hierarchy that will be revised during future sessions, introduce concept of function-based intervention, behavioral reward program, self-monitoring training, habit reversal training for their tics. They will received an introduction of relaxation techniques and diaphragmatic breathing exercise and an introduction of progressive muscle relaxation (PMR) exercise. They will received booster sessions for three months and he will do hierarchy review, inconvenience review, function-based intervention and competing response review, review of relaxation techniques and relapse prevention review.

    Behavioral: Cognitive behavioural treatment for tics

  • Experimental
    Cognitive psychophysiological (CoPs)

    The participant will received a rational about the treatment and awareness training about tics and creating list of tics. He will identifying high and low risk situations provoking tics, do video record and make a list of inconveniences of tic. He will do a screening session of the video and muscle discrimination exercises. Worked on a situational profile with a Kelly's grill and beginning relaxation and breathing exercises. He will identifying style of planning and work on it to do an advantages and inconveniences list to adopt this style. Some behavioral and cognitive re structuration about style of planning and how to modifying. At the end, he will received a relapse prevention informations and how to generalize the learnings and a record of the therapy. Finally, he will have to practice all this techniques at home for four week and do a last session to discuss home practice and received strategies for the future.

    Behavioral: Cognitive psychophysiological

Interventions

  • BehavioralCognitive behavioural treatment for tics

    Mainly based on the habit reversal treatment (HRT) and in addition to HRT components, they learn awareness training, relaxation, competing response, contingency management, and generalization training.

    Also known as: CBIT

  • BehavioralCognitive psychophysiological

    Focus on the processes influencing thoughts and behaviors underlying tics.

    Also known as: CoPs

05

What researchers measure

Primary outcomes

  1. Yale Global Tic Severity Scale (YGTSS)

    The YGTSS is a clinician-rated scale used to assess change in tic severity and impairment due to tics.

    Time frame: baseline

Secondary outcomes

  1. determine style of planning actions

    The style of planning (STOP) questionnaire was developed to assess everyday style of planning actions. The aim of the STOP was to capture the behavioural and cognitive aspects involved in adequate planning of action in a variety of everyday situations involving routing, complex tasks and both anticipation and enactment.

    Time frame: baseline

  2. measure effect of therapy in style of planning score

    The style of planning (STOP) questionnaire was developed to assess everyday style of planning actions. The aim of the STOP was to capture the behavioural and cognitive aspects involved in adequate planning of action in a variety of everyday situations involving routing, complex tasks and both anticipation and enactment.

    Time frame: change from baseline

  3. measure long term effect of therapy in style of planning score

    The style of planning (STOP) questionnaire was developed to assess everyday style of planning actions. The aim of the STOP was to capture the behavioural and cognitive aspects involved in adequate planning of action in a variety of everyday situations involving routing, complex tasks and both anticipation and enactment.

    Time frame: change from baseline at 6 months

  4. change in dimensions of perfectionism and use as a predictive variable of treatment issues

    The Frost Multidimensional Perfectionism Scale is a self-administered questionnaire of 35 items covering six dimensions of perfectionism.

    Time frame: baseline

  5. change in dimensions of perfectionism

    The Frost Multidimensional Perfectionism Scale is a self-administered questionnaire of 35 items covering six dimensions of perfectionism.

    Time frame: change from baseline

  6. measure the long term effect on dimensions of perfectionism

    The Frost Multidimensional Perfectionism Scale is a self-administered questionnaire of 35 items covering six dimensions of perfectionism.

    Time frame: change from baseline at 6 months

  7. determine the initial score of symptom of anxiety use as a predictive variable of treatment issues

    The Beck Anxiety Inventory consists of a 21-item anxiety symptom checklist rating symptom intensity for the last week on a 0-3 scale.

    Time frame: baseline

  8. measure the effect of therapy on symptom of anxiety

    The Beck Anxiety Inventory consists of a 21-item anxiety symptom checklist rating symptom intensity for the last week on a 0-3 scale.

    Time frame: change from baseline

  9. measure the long term effect of therapy on symptom of anxiety

    The Beck Anxiety Inventory consists of a 21-item anxiety symptom checklist rating symptom intensity for the last week on a 0-3 scale.

    Time frame: change from baseline at 6 months

  10. determine an initial score of symptom of depression and use as a predictive variable of treatment issues

    The Beck Depression Inventory consists of a 21-item relative to depression (α = .91), assesses cognitive, emotional and somatic depressive symptoms.

    Time frame: baseline

  11. measure the effect of therapy on symptom of depression

    The Beck Depression Inventory consists of a 21-item relative to depression (α = .91), assesses cognitive, emotional and somatic depressive symptoms.

    Time frame: change from baseline

  12. measure the long term effect of therapy on symptom of depression

    The Beck Depression Inventory consists of a 21-item relative to depression (α = .91), assesses cognitive, emotional and somatic depressive symptoms.

    Time frame: change from baseline at 6 months

  13. measure the presence and the impact on treatment issues of major life events

    Life Events Survey determine which life events have occurred in the participant life over the past two years.

    Time frame: baseline

  14. measure the presence and the impact on treatment issues of major life events

    Life Events Survey determine which life events have occurred in the participant life over the past two years.

    Time frame: change from baseline

  15. measure the presence and the impact of major life events

    Life Events Survey determine which life events have occurred in the participant life over the past two years.

    Time frame: change from baseline at 6 months

  16. determine an initial score of individual self-esteem and use as a predictive variable of treatment issues

    The Self-Esteem Inventory measure individual self-esteem

    Time frame: baseline

  17. measure the effect of the therapy on Self-Esteem

    The Self-Esteem Inventory measure individual self-esteem

    Time frame: change from baseline

  18. measure the long term effect of the therapy on Self-Esteem and use as a predictor of issues of treatment

    The Self-Esteem Inventory measure individual self-esteem

    Time frame: change from baseline at 6 months

  19. determine an initial score of individual motor and attentional impulsivity and use as a predictive variable of treatment issues

    Barrat Impulsivity Scale measure motor and attentional impulsivity

    Time frame: baseline

  20. measure the effect of the therapy on motor and attentional impulsivity

    Barrat Impulsivity Scale measure motor and attentional impulsivity.

    Time frame: change from baseline

  21. measure the long term effect of the therapy on motor and attentional impulsivity

    Barrat Impulsivity Scale measure motor and attentional impulsivity.

    Time frame: change from baseline at 6 months

  22. determine a baseline score of quality of life linked with Tourette syndrome

    Tourette syndrome quality of life questionnaire measure change in quality of life linked with symptoms of Tourette syndrome

    Time frame: baseline

  23. measuring effect of therapy on quality of life

    measure change in quality of life linked with symptoms of Tourette syndrome

    Time frame: change from baseline

  24. measuring long term effect of therapy on quality of life

    measure change in quality of life linked with symptoms of Tourette syndrome

    Time frame: change from baseline at 6 months

  25. measuring initial symptoms of ADHD and use as a predictive variable of treatment issues

    The Conners Adult and child ADHD Rating Scale - Short: Self-administered is a self-reported questionnaire which measures attention deficit hyperactivity disorder (ADHD) symptoms.

    Time frame: baseline

  26. measuring effect of therapy on symptoms of ADHD

    The Conners Adult ADHD Rating Scale - Short: Self-administered is a self-reported questionnaire which measures ADHD symptoms.

    Time frame: change from baseline

  27. measuring long term effect of therapy on symptoms of ADHD

    The Conners Adult ADHD Rating Scale - Short: Self-administered is a self-reported questionnaire which measures ADHD symptoms.

    Time frame: change from baseline at 6 months

  28. assessing symptom severity of obsessive-compulsive disorder (OCD) and use as a predictive variable of treatment issues

    The Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) is assessing symptom severity in older children (i.e., 8-18 years) diagnosed with obsessive-compulsive disorder (OCD).

    Time frame: baseline

  29. assessing change of symptom severity of obsessive-compulsive disorder (OCD)

    The Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) is assessing symptom severity in older children (i.e., 8-18 years) diagnosed with obsessive-compulsive disorder (OCD).

    Time frame: change from baseline

  30. assessing long term change of symptom severity of obsessive-compulsive disorder (OCD)

    The Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) is assessing symptom severity in older children (i.e., 8-18 years) diagnosed with obsessive-compulsive disorder (OCD).

    Time frame: change from baseline at 6 months

  31. determine an initial score of level of self-esteem use as a predictive variable of treatment issues

    The Culture Free Self-Esteem inventory is a self-report inventories used to determine the level of self-esteem in students ages 6-18 years and adults. It can be used to identify children and adolescents or adults in need of psychological assistance due to self-esteem problems, assess therapeutic progress, and evaluate post-therapy effects.

    Time frame: baseline

  32. evaluate post-therapy effects on level of self-esteem

    The Culture Free Self-Esteem inventory is a self-report inventories used to determine the level of self-esteem in students ages 6-18 years and adults. It can be used to identify children and adolescents or adults in need of psychological assistance due to self-esteem problems, assess therapeutic progress, and evaluate post-therapy effects.

    Time frame: change from baseline

  33. evaluate long term post-therapy effects on level of self-esteem

    The Culture Free Self-Esteem inventory is a self-report inventories used to determine the level of self-esteem in students ages 6-18 years and adults. It can be used to identify children and adolescents or adults in need of psychological assistance due to self-esteem problems, assess therapeutic progress, and evaluate post-therapy effects.

    Time frame: change from baseline at 6 months

  34. change in the global measure of level of functionning in children, adolescents and adults

    The Childrens Global Assessment Scale (CGAS) and the global assessment scale (GAS) they are global measures of level of functioning in children and adolescents and adult. This measures provides a single global rating only, on scale of 0-100. In making their rating, the clinician makes use of the glossary details to determine the meaning of the points on the scale.

    Time frame: baseline

  35. change in the global measure of level of functionning in children, adolescents and adults

    The Childrens Global Assessment Scale (CGAS) and the global assessment scale (GAS) they are global measures of level of functioning in children and adolescents and adult. This measures provides a single global rating only, on scale of 0-100. In making their rating, the clinician makes use of the glossary details to determine the meaning of the points on the scale.

    Time frame: change from baseline

  36. change in the global measure of level of functionning in children, adolescents and adults

    The Childrens Global Assessment Scale (CGAS) and the clinical global assessment of functionning scale (GAF) are global measures of level of functioning in children and adolescents and adult. This measures provides a single global rating only, on scale of 0-100. In making their rating, the clinician makes use of the glossary details to determine the meaning of the points on the scale.

    Time frame: change from baseline at 6 months

Other outcomes

  1. Intelligence and executive functioning screening assessment

    General intelligence evaluation with subscales of the Wechsler Adult Intelligence Scale or the Wechsler Intelligence Scale for Children, (WAIS-III or WISC-V - Vocabulary, block and similitude).

    Time frame: baseline

  2. Intelligence and executive functioning screening assessment

    General intelligence evaluation with subscales of the Wechsler Adult Intelligence Scale or the Wechsler Intelligence Scale for Children, (WAIS-III or WISC-V - Vocabulary, block and similitude).

    Time frame: change from baseline

  3. The Brief Inventory of Executive Function (BRIEF-A)

    Is a standardized 75-item questionnaire designed to assess adult's and children's views of their everyday environment.

    Time frame: baseline

  4. The Brief Inventory of Executive Function (BRIEF-A)

    Is a standardized 75-item questionnaire designed to assess adult's and children's views of their everyday environment.

    Time frame: change from baseline

  5. Motor function

    The assessment of fine motor dexterity by the Purdue pegboard test and for the evaluation of motor speed and control, the finger tapping task will be administered.

    Time frame: baseline

  6. Motor function

    The assessment of fine motor dexterity by the Purdue pegboard test and for the evaluation of motor speed and control, the finger tapping task will be administered.

    Time frame: change from baseline

06

Study locations

1 site
  • Centre de recherche de l'Institut universitaire en santé mentale de Montréal
    Montréal-Est, Quebec H1N 3V2, Canada
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03225430
Lead sponsor
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Frederick Aardema (Professeur titulaire, Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal) — Principal investigator
First posted
Jul 21, 2017
Start date
Apr 21, 2016
Primary completion
Sep 1, 2021
Completion
Sep 1, 2021
Last update
Jul 15, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion